World Rose Day: Vedanta’s BALCO Medical Centre bolsters cancer care in India
22nd September 2023
- On the occasion, the BALCO Medical Centre organized a series of activities including healthcare awareness programs and yoga sessions
New Delhi; 22nd September 2023: On World Rose Day, Vedanta’s BALCO Medical Centre (BMC), one of India’s leading cancer care hospitals, reaffirms its commitment to providing quality healthcare service to cancer patients, especially those hailing from rural India. The state-of-the-art cancer treatment centre, which commenced operations in 2018, has since gone on to establish itself as a national leader in India’s oncological care landscape. On the occasion of World Rose Day, BMC undertook several initiatives to build awareness around cancer and acknowledge the tenacity demonstrated daily by cancer fighters and survivors.
World Rose Day is observed internationally as an occasion to encourage cancer patients in their fight against the disease, one of the most prevalent illnesses today. The possibility of preventing and successfully mitigating the incidence of cancer is enhanced greatly through timely diagnosis followed by quality treatment. Thus, the commemoration of World Rose Day included an informative lecture in collaboration with Samarth, a dedicated patient support network within BMC. This session empowered patients and their families with essential knowledge about cancer-related issues. It also included a rejuvenating yoga session that provided participants with a holistic approach to their overall well-being. The day’s events culminated in the distribution of roses to the patients, honouring their courage and resilience.
The BALCO Medical Centre is the most preferred oncology hospital in central India for advanced radiation therapy, brachytherapy, nuclear medicine, surgeries, chemotherapy, immunotherapy, blood-related disorders, plastic and reconstructive surgery, and pain & palliative care. Situated in Raipur, Chhattisgarh, the cutting-edge medical facility boasts 170 beds and state-of-the-art diagnostic and therapeutic capabilities. Since its inception, BMC has diligently served the healthcare needs of over 35,000 patients, addressing existing gaps in domestic cancer treatment, awareness, infrastructure and expertise. Furthermore, the centre has forged comprehensive research and knowledge alliances with prestigious institutions in the field, including the Tata Memorial Centre (TMC) in Mumbai and Anuva, a transnational research company specializing in genomics biotech.
On the occasion, Ms. Jyoti Agarwal, Chairperson of BALCO Medical Centre said, “We believe that healthy societies are the driver of inclusive development. Through the BALCO Medical Centre and its health interventions, we aim to revolutionize universal access to cancer care. By strengthening healthcare infrastructure, providing quality services for cancer care and promoting a proactive stance in maintaining health, we are helping create a step change in community wellbeing and a healthier, happier society across India.”
Underscoring the impact of the BALCO Medical Centre’s efforts, Dr Bhawna Sirohi, Medical Director of BMC, added, “World Rose Day is an occasion to celebrate the courage displayed by cancer patients, and recognise the efforts of care providers as well. BALCO Medical Centre is staffed by a committed team of experts committed to exploring new frontiers of technologies in their effort to provide best-in-class treatment, while also inspiring greater monitoring, healthier lifestyles, and timely interventions.”
Set up under the aegis of the Vedanta Medical Research Foundation (VMRF) and backed by the Anil Agarwal Foundation (AAF), the BALCO Medical Centre is making a difference in the lives of lakhs of people through increased access to quality medical care. BMC’s extensive roster of renowned cancer specialists regularly organises efforts to educate individuals on the cruciality of timely preventive screening and mitigation measures against various forms of cancer. Dedicated medical experts from the centre reach out to students, working professionals and other community members through several platforms such as awareness talks, health camps, and webinars. Along with cancer treatment, all patients at BALCO Medical Centre also receive robust psychological, nutritional and physical therapy, in addition to membership in patient support groups for emotional support during their care period.
For more information, visit: https://www.balcomedicalcentre.com/
About Vedanta Limited:
Vedanta Limited, a subsidiary of Vedanta Resources Limited, is one of the world’s leading Oil & Gas and Metals company with significant operations in Oil & Gas, Zinc, Lead, Silver, Copper, Iron Ore, Steel, and Aluminium & Power across India, South Africa and Namibia. For two decades, Vedanta has been contributing significantly to nation building. Governance and sustainable development are at the core of Vedanta's strategy, with a strong focus on health, safety, and environment. Vedanta has put in place a comprehensive framework to be the ESG leader in the natural resources sector. Vedanta is committed to reducing carbon emissions to zero by 2050 or sooner and has pledged $5 billion over the next 10 years to accelerate the transition to net zero operations. Giving back is in the DNA of Vedanta, which is focused on enhancing the lives of local communities. The company’s flagship social impact program, Nand Ghars, have been set up as model anganwadis focused on eradicating child malnutrition, providing education, healthcare, and empowering women with skill development. Under the aegis of the Anil Agarwal Foundation, the umbrella entity for Vedanta’s social initiatives, the Vedanta group has pledged Rs 5000 crore over the next five years on social impact programmes with a thrust on nutrition, women & child development, healthcare, animal welfare, and grass-root level sports. Vedanta and the group companies have been featured in Dow Jones Sustainability Index, and was conferred Frost & Sullivan Sustainability Awards 2020, Golden Peacock Award for excellence in Corporate Governance 2022 and certified as a Great Place to Work 2022. Vedanta Limited is listed on the Bombay Stock Exchange and the National Stock Exchange.
For more information, please visit www.vedantalimited.com
About Vedanta Aluminium Business:
Vedanta Aluminium, a business of Vedanta Limited, is India’s largest producer of aluminium, manufacturing more than half of India’s aluminium i.e., 2.37 million tonnes in FY24. It is a leader in value-added aluminium products that find critical applications in core industries. Vedanta Aluminium ranks 1st in the S&P Global Corporate Sustainability Assessment 2023 world rankings for the aluminium industry, a reflection of its leading sustainable development practices. With its world-class aluminium smelters, alumina refinery and power plants in India, the company fulfils its mission of spurring emerging applications of aluminium as the ‘Metal of the Future’ for a greener tomorrow.
For more information, please log on to www.vedantaaluminium.com
Follow us on LinkedIN, Facebook, Twitter, Instagram
Disclaimer:
This press release contains “forward-looking statements” – that is, statements related to future, not past, events. In this context, forward-looking statements often address our expected future business and financial performance, and often contain words such as “expects,” “anticipates,” “intends,” “plans,” “believes,” “seeks,” “should” or “will.” Forward-looking statements by their nature address matters that are, to different degrees, uncertain. For us, uncertainties arise from the behaviour of financial and metals markets including the London Metal Exchange, fluctuations in interest and or exchange rates and metal prices; from future integration of acquired businesses; and from numerous other matters of national, regional, and global scale, including those of a political, economic, business, competitive or regulatory nature. These uncertainties may cause our actual future results to be materially different than those expressed in our forward-looking statements. We do not undertake to update our forward-looking statements.
